Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Future Oncology (London, England)|September 3, 2020
Belantamab mafodotin in the treatment of relapsed or refractory multiple myelomaSemira Sheikh, Eyal Lebel, Suzanne TrudelCancers|April 27, 2024
Immune Therapies in AL Amyloidosis-A Glimpse to the FutureArnon Haran, Iuliana Vaxman, Moshe E Gatt, et al.Journal of Clinical Medicine|April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple MyelomaEyal Lebel, Boaz Nachmias, Marjorie Pick, et al.Hormone Research in Paediatrics|August 28, 2012
Euthyroid submedian free T4 and subclinical hypothyroidism may have a detrimental clinical effect in Down syndromeAriel Tenenbaum, Eyal Lebel, Sarah Malkiel, et al.Leukemia & Lymphoma|December 29, 2021
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcomeEyal Lebel, Vladimir Vainstein, Maayan Ashkenazi, et al.British Journal of Haematology|August 4, 2020
Characteristics and outcomes of adults with cytomegalovirus-associated thrombocytopenia: a case series and literature reviewTamir Shragai, Eyal Lebel, Dana Deshet, et al.Transplantation and Cellular Therapy|May 9, 2023
Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell TransplantationYarden Irit Cohen, Eyal Lebel, Eran Zimran, et al.Oncology Research and Treatment|December 9, 2020
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System LymphomaStav Gazal, Eyal Lebel, Yosef Kalish, et al.Journal of Clinical Medicine|May 28, 2022
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and SurvivalNoa Gross Even-Zohar, Marjorie Pick, Liron Hofstetter, et al.Acta Haematologica|April 4, 2019
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell LymphomaBoaz Nachmias, Adir Shaulov, David Lavie, et al.Pageof 4